Cannabis Law Report
NOVEMBER 16, 2021
As cleared by the FDA, the primary endpoint of the Phase 2 double-blind, placebo-controlled clinical trial is to achieve a reduction in the circulating levels of tumor necrosis factor-alpha (TNF-?), The secondary measures will be the safety, tolerability, and pharmacokinetics in this population of patients.
Cannabis Law Report
JANUARY 5, 2022
This patent issuance is rewarding and timely as we launch our Phase 2 trial of MYMD-1 as a therapy for sarcopenia, frailty, and aging, which is currently recruiting patients,” said Chris Chapman, M.D., The patent will be issued on January 11, 2022. President, Director and Chief Medical Officer of MyMD.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Cannabis Law Report
JUNE 25, 2021
billion in 2025 at a CAGR of 14%. EMA also regulates and supervises the drug quality, check for the intended use of the drug and whether the drug is meeting the requirement of clinical trial. The market is expected to reach $2.72 The skin cancer drugs market consists of sales of skin cancer drugs.
Cannabis Law Report
DECEMBER 23, 2021
billion by 2025. The market sizing section provides forecasts on the estimated sales of the three most lucrative cannabinoid pharmaceuticals – from 2021-2025 – including Epidiolex, Sativex and Dronabinol. Global surveys of cannabis users indicate that around 40% of users have some medical component to their usage.
SpeedWeed
MARCH 19, 2021
Regular doses of CBD could help prevent cognitive decline in Alzheimer’s patients, according to a new study recently published in the Journal of Alzheimer’s Disease. Prior research has already linked Alzheimer’s to high levels of beta-amyloid plaque, a sticky compound that forms in the brains of AD patients.
Cannabis Law Report
JULY 15, 2022
“It’s very important from our perspective to ensure that the Australian patient gets medicine first. The first medicinal cannabis ‘mother’ plants are expected to be imported from Israel within a month, with manufacturing scheduled to begin within the first half of this year, to supply 5,000 Australian patients.
SMPL
MAY 26, 2020
Miller spent the months after this meeting leading hundreds of CBD seminars for farmers; Dr. Kerr began informal patient surveys to track how CBD made people feel; and as he finished his book, Mr. Lee often traveled around with Mr. Laughter and Mr. Ringo’s high-CBD plants and seeds, spreading the gospel at pot shops across the West.
Expert insights. Personalized for you.
52 
Let's personalize your content